Author:
Doyle Tom A.,Schmidt Karen K.,Halverson Colin M.E.,Olivera Jesus,Garcia Abigail,Shugg Tyler A.,Skaar Todd C.,Schwartz Peter H.
Funder
Indiana University School of Medicine
Indiana University
Reference48 articles.
1. Identification of populations likely to benefit from pharmacogenomic testing;Heise;Pharm Genom,2020
2. Projected prevalence of actionable pharmacogenetic variants and level a drugs prescribed among us veterans health administration pharmacy users;Chanfreau-Coffinier;JAMA Netw Open,2019
3. IGNITE Network. Implementation Guides. IGNITE. Accessed September 20, 2022. 〈https://gmkb.org/implementation-guides/〉.
4. Updating the landscape of direct-to-consumer pharmacogenomic testing;Filipski;Pharm Pers Med,2017
5. Pharmacogenomic clinical decision support: a review, how‐to guide, and future vision;Wake;Clin Pharm Ther,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献